| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000035408 |
| Receipt No. | R000040292 |
| Scientific Title | The Effectiveness of Handgrip exercise in Hypertension |
| Date of disclosure of the study information | 2019/01/01 |
| Last modified on | 2020/07/07 (Ver. 6) |
| Basic information | ||
| Public title | The Effectiveness of Handgrip exercise in Hypertension | |
| Acronym | The Effectiveness of Handgrip exercise in Hypertension | |
| Scientific Title | The Effectiveness of Handgrip exercise in Hypertension | |
| Scientific Title:Acronym | The Effectiveness of Handgrip exercise in Hypertension | |
| Region |
|
|
| Condition | ||
| Condition | Hypertension | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | We investigate the effectiveness of hand grip exercise. We conduct double blind random control trial of handgrip exercise in hypertensive patients for 3 months. Then we follow up with both groups for 12 months as a prospective cohort study to see if the effectiveness of their exercise can last long term. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Systolic and diastolic blood pressure at both clinic visit and home at 12 weeks |
| Key secondary outcomes | Home blood pressure at 4,8 weeks and 6,9,12 months. Systolic and Diastolic blood pressure at clinic visit at 6,9,12 months.
compliance of handgrip exercise over 12 weeks the rate of concordance in 30% handgrip exercise machine and the rate of concordance in placebo machine. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | NO |
| Concealment | Numbered container method |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | participants undergo isometric hand grip exercise:four sets of 2-min isometric contractions(using alternate hands) on a programmed handgrip dynamometer(medical grip;Ohashi Chiso Laboratory,Tokyo,Japan)at 30% of maximal voluntary contraction,each separated by a 1-min rest interval.(turning on blue lamp for right grip, yellow lamp for too weak,red for too strong.) Participants will continue exercise for 12 weeks, then we open the label and ask the volunteer if they want to continue the exercise for another 9 months. | |
| Interventions/Control_2 | participants undergo isometric hand grip exercise:four sets of 2-min isometric contractions(using alternate hands) on a programmed handgrip dynamometer(medical grip;Ohashi Chiso Laboratory,Tokyo,Japan)at 15% of maximal voluntary contraction,each separated by a 1-min rest interval.(turning on blue lamp for right grip, yellow lamp for too weak,red for too strong.) Participants will continue the exercise for 12 weeks. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1.Diagnosed Hypertension 4 weeks prior to participate the study. Diagnostic criteria is 140/90 mmHg.
2.Holding home blood pressure monitor and able to measure blood pressure at home. |
|||
| Key exclusion criteria | 1.resting SBP is more than 180 mmHg at the beginning.
2.Changed anti-hypertensive medication within 4 weeks. 3.continuous physical training more than 3 times per week more than 4 weeks before the study. 4.History of peripheral vascular disease and Presenting symptoms. 5.History of congestive heart failure and presenting symptoms more than NYHA 2. 6.uncontrolled arrhythmias or presenting symptoms of arrhythmias. 7. History of acute coronary syndrome or cerebral vascular disease within 4 weeks. 8.History of osteoarthritis or any orthotic disease which make participants difficult to perform handgrip exercise. 9.Any history or present illness which primary care doctor decide that participants are unable to perform handgrip exercise. |
|||
| Target sample size | 100 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Kameda Family Clinic at Tateyama | ||||||
| Division name | Family Medicine | ||||||
| Zip code | 294-0051 | ||||||
| Address | 4304-9 Masaki, Tateyama-shi, Chiba | ||||||
| TEL | 0470-20-5520 | ||||||
| office.kfct@gmail.com | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Kameda Family Clinic at Tateyama | ||||||
| Division name | Family Medicine | ||||||
| Zip code | 294-0051 | ||||||
| Address | 4304-9 Masaki, Tateyama-shi, Chiba | ||||||
| TEL | 0470-20-5520 | ||||||
| Homepage URL | |||||||
| office.kfct@gmail.com | |||||||
| Sponsor | |
| Institute | Medical Corporation Tesshokai |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Self funding |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Medical Corporation Tesshokai IRB |
| Address | 929 Higashi-cho, Kamogawa City, Chiba Prefecture, Japan 296-8602 |
| Tel | 04-7092-2211 |
| clinical_research@kameda.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 医療法人鉄蕉会亀田ファミリークリニック館山 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000040292 |